Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data
NCT05313854 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2022-04-06
Summary
This prospective cohort study is designed to investigate the diagnostic ability and prediction accuracy of pancreatic cancer by radiomics data and clinical data.
Conditions
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Principal Investigators
-
Tao Chen, Dr · Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- China
Study Locations
More Related Trials
-
A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients
NCT05138302 ·Status: UNKNOWN
-
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
NCT06638866 ·Status: RECRUITING
-
Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
NCT06849063 ·Status: RECRUITING
-
Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
NCT05476978 ·Status: COMPLETED
-
Impact of Three-dimensional Visualization on Operation Strategy and Complications for Pancreatic Cancer
NCT03749005 ·Status: UNKNOWN
-
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147 ·Status: RECRUITING
-
Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial
NCT05253313 ·Status: UNKNOWN ·Phase: NA
-
Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer
NCT02745847 ·Status: UNKNOWN ·Phase: NA
-
A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma
NCT06336694 ·Status: COMPLETED
-
Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer
NCT04977596 ·Status: COMPLETED
-
A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC
NCT06267690 ·Status: COMPLETED
-
Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis
NCT06760234 ·Status: COMPLETED
-
Research of the Application of Artificial Intelligence Model "PANDA"
NCT06528223 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy
NCT07243288 ·Status: ACTIVE_NOT_RECRUITING
-
Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer
NCT04699539 ·Status: COMPLETED ·Phase: NA
-
Radiomics in Pancreatic Cancer
NCT05658679 ·Status: UNKNOWN
-
Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI
NCT05511116 ·Status: UNKNOWN
-
Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer
NCT05848154 ·Status: NOT_YET_RECRUITING
-
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT07271823 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
NCT06151223 ·Status: RECRUITING
-
Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses
NCT04603586 ·Status: COMPLETED ·Phase: NA
-
Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife
NCT02716207 ·Status: COMPLETED ·Phase: NA
-
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
NCT04281511 ·Status: COMPLETED
-
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer
NCT05802394 ·Status: RECRUITING ·Phase: NA
-
Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model "PANDAPro"
NCT06643715 ·Status: RECRUITING ·Phase: NA